Dark

Check out our Dark Pool Levels

KIN
Kindred Biosciences, Inc.
stock NASDAQ

Inactive

Aug 27, 2021

9.25USD+0.108%(+0.01)178,496

Pre-market

0.00USD-100.000%(-9.24)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Aug 10, 2021

02:42PM EDT The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs Benzinga

Jun 23, 2021

12:01PM EDT SHAREHOLDER ALERT: WeissLaw LLP Reminds KIN, FMBI, SLCT, and CNST GlobeNewswire Inc

Jun 21, 2021

01:24PM EDT KINDRED BIOSCIENCES INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kindred Biosciences, Inc. - KIN Business Wire

Jun 18, 2021

10:20AM EDT Looking Into Kindred Biosciences's Return On Capital Employed Benzinga

07:46AM EDT The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs Benzinga

Jun 17, 2021

11:37AM EDT Lake Street Downgrades Kindred Biosciences to Hold, Lowers Price Target to $9.25 Benzinga

10:02AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 17, 2021 Benzinga

09:17AM EDT HC Wainwright & Co. Downgrades Kindred Biosciences to Neutral, Raises Price Target to $9.25 Benzinga

08:33AM EDT The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme Benzinga

Jun 16, 2021

02:32PM EDT Mid-Afternoon Market Update: Dow Tumbles Over 300 Points; Federal Reserve Maintains Interest Rates Benzinga

12:14PM EDT SHAREHOLDER ALERT: WeissLaw LLP Investigates Kindred Biosciences, Inc. GlobeNewswire Inc

12:03PM EDT Mid-Day Market Update: Dow Falls 40 Points; Aprea Therapeutics Shares Surge Benzinga

10:17AM EDT Mid-Morning Market Update: Markets Mixed; Elanco Animal Health To Acquire Kindred Biosciences Benzinga

10:06AM EDT Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2021 Benzinga

09:24AM EDT Aegis Capital Downgrades Kindred Biosciences to Hold, Lowers Price Target to $9.25 Benzinga

07:07AM EDT Elanco Animal Health Inc. (ELAN) and veterinary biopharmaceutical company Kindred Biosciences, Inc. (KIN) announced Wednesday they have entered into a definitive agreement for Elanco to acquire Kindred for $9.25 per share, or approximately $440 million. RTTNews

06:51AM EDT Kindred Biosciences Stock Jumps On $440M Elanco Animal Buyout Deal Benzinga

06:33AM EDT Elanco Animal Health To Acquire Kindred Biosciences At $9.25/Shr RTTNews

06:31AM EDT Elanco Announces Agreement To Acquire Kindred Biosciences For $9.25/Share Benzinga

06:30AM EDT Elanco Announces Agreement to Acquire Kindred Biosciences PR Newswire

Jun 4, 2021

09:39AM EDT The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact Benzinga

Jun 3, 2021

11:13AM EDT Kindred Biosciences Insights: Return On Capital Employed Benzinga

Jun 2, 2021

08:38AM EDT Kindred Biosciences Announces Results From Pivotal Efficacy Study Of Parvovirus Monoclonal Antibody; Results Showed 100% Survival In Treated Group vs 43% Survival In Placebo Group Benzinga

08:38AM EDT Kindred Biosciences Announced Positive Results From Pivotal Efficacy Study Of KIND-030 In Dogs Infected By Parvovirus RTTNews

08:38AM EDT Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus PR Newswire

May 25, 2021

08:42AM EDT Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference PR Newswire

May 11, 2021

05:01PM EDT Kindred Biosciences: Q1 Earnings Insights Benzinga

05:00PM EDT CORRECTION: Kindred Biosciences Q1 Sales $2.40M Miss $3.45M Estimate Benzinga

05:00PM EDT Kindred Biosciences Q1 EPS $(0.24), Inline, Sales $2.40M Miss $3.45M Estimate Benzinga

04:03PM EDT Kindred Biosciences Announces First Quarter 2021 Financial Results PR Newswire

12:47PM EDT Earnings Scheduled For May 11, 2021 Benzinga

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

04:14AM EDT Earnings Scheduled For May 11, 2021 Benzinga

May 3, 2021

08:42AM EDT Kindred Biosciences to Announce First Quarter 2021 Financial Results PR Newswire

Apr 28, 2021

08:36AM EDT Kindred Biosciences Announces Acceptance Of Parvovirus Antibody Prophylaxis Study Data And Approval Of Efficacy Indication Benzinga

08:32AM EDT Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis PR Newswire

Apr 21, 2021

06:38AM EDT Kindred's New IL-31 Antibody Shows Improved Shelf Life In PK Study For Canine Dermatitis Benzinga

Apr 20, 2021

04:04PM EDT Kindred Biosciences Announces Results From Its Long-Acting Interleukin-31 Antibody PK Study Benzinga

04:03PM EDT Kindred Biosciences Unveils Positive Results from its Long-Acting PR Newswire

Mar 16, 2021

04:03PM EDT Kindred Biosciences Q4 EPS $(0.28) Beats $(0.29) Estimate, Sales $1.00M Inline Benzinga

04:02PM EDT Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial PR Newswire

08:17AM EDT The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study Benzinga

04:46AM EDT Earnings Scheduled For March 16, 2021 Benzinga

Mar 14, 2021

08:14AM EDT Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations Benzinga

Mar 8, 2021

08:47AM EST Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial PR Newswire

Mar 2, 2021

08:32AM EST Kindred Biosciences to Present at Barclays Global Healthcare Conference and PR Newswire

Feb 25, 2021

01:37PM EST Kindred Biosciences Submits Efficacy Data For KIND-030 As Prophylactic Option In US Benzinga

08:20AM EST Kindred Biosciences Reports Submission Of Parvovirus Monoclonal Antibody Data From Prophylactic Indictino Benzinga

08:03AM EST Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data PR Newswire

Feb 16, 2021

04:02PM EST Kindred Biosciences to Present at the BofA Securities Animal Health Virtual PR Newswire

Feb 9, 2021

08:36AM EST Kindred Biosciences Appoints Lyndon Lien And Nanxi Liu To Board RTTNews

08:32AM EST Kindred Biosciences Announces Two New Appointments to Board of Directors PR Newswire

Jan 26, 2021

09:35AM EST Aegis Capital Maintains Buy on Kindred Biosciences, Raises Price Target to $16 Benzinga

Dec 22, 2020

08:39AM EST Kindred Initiates Pivotal Efficacy Study Of Tirnovetmab Monoclonal Antibody For Canine Atopic Dermatitis RTTNews

08:32AM EST Kindred Biosciences Initiates Pivotal Efficacy Study Of Tirnovetmab Monoclonal Antibody For Canine Atopic Dermatitis Benzinga

08:31AM EST Kindred Biosciences Initiates Pivotal Efficacy Study of Tirnovetmab PR Newswire

Dec 21, 2020

09:32AM EST Kindred Report Positive Results From Pilot Field Effectiveness Study For Anti-TNF Antibody RTTNews

08:49AM EST Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness Study for Anti-TNF Antibody for Canine Inflammatory Bowel Disease Benzinga

08:31AM EST Kindred Biosciences Announces Positive Results from Pilot Field Effectiveness PR Newswire

Dec 11, 2020

08:13AM EST Elanco Reaches Deal With Kindred To Acquire Global Rights RTTNews

08:04AM EST Elanco Animal Health Enters Agreement With Kindred Biosciences To Acquire Exclusive Global Rights To KIND-030 RTTNews

08:02AM EST Elanco Reports Deal with KindredBio For Canine Parvovirus Therapy To Market; Global License Includes $500K Upfront Payment, Added Milestones Benzinga

08:01AM EST Kindred Biosciences Announces Agreement Granting Elanco Exclusive Global Rights PR Newswire

Dec 2, 2020

04:02PM EST Kindred Biosciences to Present at Guggenheim Animal Health Summit PR Newswire

Nov 11, 2020

08:32AM EST Kindred Biosciences to Participate in Stifel Virtual Healthcare Conference and PR Newswire

Nov 9, 2020

04:05PM EST Kindred Biosciences Q3 EPS $(0.31) Misses $(0.30) Estimate, Sales $1.04M Beat $560.00K Estimate Benzinga

04:02PM EST Kindred Biosciences Announces Third Quarter 2020 Financial Results PR Newswire

04:13AM EST Earnings Scheduled For November 9, 2020 Benzinga

Nov 8, 2020

03:58PM EST The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions Benzinga

12:47PM EST The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs Benzinga

Oct 28, 2020

04:06PM EDT Kindred Biosciences to Announce Third Quarter 2020 Financial Results PR Newswire

Oct 7, 2020

08:35AM EDT Kindred Biosciences Inc. (KIN) said Wednesday that it has expanded an agreement with Vaxart Inc. (VXRT) to manufacture Vaxart's oral vaccine for COVID-19 and other vaccine candidates. RTTNews

08:10AM EDT Kindred Expands Agreement With Vaxart For Manufacture Of Oral Vaccine For COVID-19 And Other Vaccine Candidates RTTNews

08:05AM EDT Kindrid Biosciences Subsidiary Centaur Announces Expansion Of Manufacturing Agreement With Vaxart For Coronavirus And Other Vaccine Candidates Benzinga

08:02AM EDT Centaur Biopharmaceutical Services Announces Expansion of Manufacturing PR Newswire

08:01AM EDT Kindred Biosciences Announces Expansion of Manufacturing Agreement with Vaxart PR Newswire

Sep 16, 2020

02:57PM EDT Why Kindred Biosciences Is Trading Higher Today Benzinga

11:02AM EDT Shares of Kindred Biosciences, Inc. (KIN), are rising more than 17% Wednesday morning after the company, which develops biologics drugs for pets, announced positive results from the pivotal efficacy study of KIND-030, a monoclonal antibody targeting canine parvovirus (CPV). RTTNews

08:05AM EDT Kindred Biosciences Announces Positive Results From Pivotal Efficacy Study Of Parvovirus Monoclonal Antibody Benzinga

08:05AM EDT Kindred Biosciences Reports Positive Results From Pivotal Efficacy Study Of KIND-030 RTTNews

08:03AM EDT Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of PR Newswire

Sep 9, 2020

08:02AM EDT Conference, Cantor Global Healthcare Conference and Lake Street Best Ideas Growth Conference PR Newswire

Aug 5, 2020

04:27PM EDT Kindred Biosciences Q2 EPS $0.60 Up From $(0.37) YoY, Sales $39.57M May Not Compare To $10.54M Estimate Benzinga

04:02PM EDT Kindred Biosciences Announces Second Quarter 2020 Financial Results PR Newswire

04:21AM EDT Earnings Scheduled For August 5, 2020 Benzinga

Jul 29, 2020

08:57AM EDT Cantor Fitzgerald Maintains Overweight on Kindred Biosciences, Lowers Price Target to $11 Benzinga

Jul 23, 2020

08:32AM EDT Kindred Biosciences to Announce Second Quarter 2020 Financial Results PR Newswire

Share